Comparison of the neuroprotective effects of the newly developed oximes (K027, K048) with trimedoxime in tabun-poisoned rats

Journal of Applied Biomedicine

Volumn 4, Issue 3, 2006, Pages 123-134

  Kassa, Jiří ^a   Kunešová, Gabriela ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Neuroprotective; Neurotoxicity; Oxime; Rat; Tabun

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; 1 (4 HYDROXYIMINOMETHYLPYRIDINIUM) 3 (4 CARBAMOYLPYRIDINIUM)BUTANE DIBROMIDE; 1 (4 HYDROXYIMINOMETHYLPYRIDINIUM) 3 (4 CARBAMOYLPYRIDINIUM)PROPANE DIBROMIDE; ATROPINE; K 027; K 048; OBIDOXIME; OXIME DERIVATIVE; PRALIDOXIME; TABUN; TRIMEDOXIME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOMATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; LETHALITY; MALE; MONITORING; MOTOR ACTIVITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; RAT; STRUCTURE ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33751350644     PISSN: 1214021X     EISSN: 12140287     Source Type: Journal    
DOI: 10.32725/jab.2006.013     Document Type: Article

References (34)

1. Bajgar J.: The Use of Chemical Weapons and Negotiations on their Ban: from History to the Present Time (in Czech). Nukleus Hradec Kralove, Czech Republic, 2006.
2. Cabal J., Bajgar J.: Tabun - reappearance 50 years later (in Czech). Chem. Listy, 93:27-31, 1999.
3. Cabal J., Kuca K., Kassa J.: Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Pharmacol. Toxicol. 95:81-86, 2004.
4. Cassel G., Karlsson L., Waara L. et al.: Pharmacokinetics and effects of HI-6 in blood and brain of soman-intoxicated rats: A microdialysis study. Eur. J. Pharmacol. 332:43-52, 1997.
5. Dawson R.M.: Review of oximes available for treatment of nerve agent poisoning. J. Appl. Toxicol. 14:317-331, 1994.
6. Dohnal V., Kuca K., Jun D.: Prediction of a new broad-spectrum reactivator capable of reactivating acetylcholinesterase inhibited by nerve agents. J Appl. Biomed. 3:139-145, 2005.
7. Eto M.: Organophosphorus Pesticides: Organic and Biological Chemistry. CRC Press Inc., Cleveland, USA, 1976.
8. Frantik E., Hornychova M.: Clustering of neurobehavioral measures of toxicity. Homeostasis 36:19-25, 1995.
9. Hornychova M., Frantik E., Kubat J., Formanek J.: Neurotoxicity profile of supermethrin, a new pyrethroid insecticide. Cent. Eur. J. Publ. Health 3:210-218, 1995.
10. Jokanovic M.: Anticholinesterase activity and delayed neurotoxic effects of tabun in hens. Vojvosanit. Pregl. 50:451-456, 1993.
11. Jokanovic M., Maksimovic M., Kilibarda V. et al.: Oxime-induced reactivation of acetycholinesterase inhibited by phosphoramidates. Toxicol. Lett. 85:35-39, 1996.
12. Kassa J.: Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J. Toxicol. Clin. Toxicol. 40:803-816, 2002.
13. Kassa J., Cabal J.: A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 132:111-118, 1999a.
14. Kassa J., Cabal J.: A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol. Toxicol. 84:41-45, 1999b.
15. Kassa J., Cabal J., Kuca K.: A comparison of the efficacy of currently available oximes against tabun in rats. Biologia 60, Suppl. 17:77-79, 2005.
16. Kassa J., Koupilova M.: The importance of anticholinergic drug selection for the neuroprotective effects of antidotes in soman-poisoned rats. Homeostasis 12:52-53, 2000.
17. Kassa J., Krejcova G.: Neuroprotective effects of currently used antidotes in tabun-poisoned rats. Pharmacol. Toxicol. 92:258-264, 2003.
18. Kassa J., Kuca K., Cabal J., Paar M.: A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. J. Toxicol. Environ. Health 69, 2006, in press.
19. Kassa J., Kunesova G.: A comparison of the potency of newly developed oximes (K027, K048) and commonly used oximes (obidoxime, HI-6) to counteract tabun-induced neurotoxicity in rats. J. Appl. Toxicol. 26, published online 21. March 2006.
20. Kuca K., Bielavsky J., Cabal J., Bielavska M.: Synthesis of a potential reactivator of acetylcholinesterase 1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)-propane dibromide. Tetrahedron Lett. 44:3123-3125, 2003a.
21. Kuca K., Bielavsky J., Cabal J., Kassa J.: Synthesis of a new reactivator of tabun inhibited acetylcholinesterase. Bioorg. Med. Chem. Lett. 13:3545-3547, 2003b.
22. Kuca K., Kassa J.: A comparison of the ability of a new bispyridinium oxime-1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods. J. Enzyme Inhib. Med. Chem. 18:529-535, 2003.
23. Kuca K., Kassa J.: In vitro reactivation of acetylcholinesterase using the oxime K027. Vet. Hum. Toxicol. 46:15-18, 2004.
24. Marrs T.C.: Organophosphate poisoning. Pharmacol. Ther. 58:51-66, 1993.
25. McDonough J.H.Jr., Zoeffel L.D., McMonagle J. et al.: Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea-pigs. Epilepsy Res. 38:1-14, 2000.
26. Moser V.C., Tilson H., McPhail R.C. et al.: The IPCS collaborative study on neurobehavioral screening methods: II. Protocol design and testing procedures. Neurotoxicology 18:929-938, 1997.
27. Ohtomi S., Takase M., Kumagai F.: Sarin poisoning in Japan. A clinical experience in Japan Self Defense Force (JSDF) Central Hospital. Int. Rev. Arm. Ser. 69:97-102, 1996.
28. Patocka J., Cabal J., Kuca K., Jun D.: Oxime reactivation of acetylcholinesterase inhibited by toxic phosphorus esters: in vitro kinetics and thermodynamics. J. Appl. Biomed. 3:91-99, 2005.
29. Poziomek E.J., Hackley B.E., Steinberg G.M.: Pyridinium aldoximes. J. Org. Chem., 23:714-717, 1958.
30. Puu G., Artursson E., Bucht G.: Reactivation of nerve agent inhibited acetylcholinesterase by HI-6 and obidoxime. Biochem. Pharmacol. 35:1505-1510, 1986.
31. Roth Z., Josifko M., Maly V., Trčka V.: Statistical Methods in Experimental Medicine (in Czech) SZN, Czechoslovakia, 1962.
32. Sakurada K., Matsubara K., Shimizu K. et al.: Pralidoxime iodide (2-PAM) penetrates across the blood-brain barrier. Neurochem. Res. 28:1401-1407, 2003.
33. Taylor P.: Anticholinesterase agents. In: J. G. Hardman and L. E. Limbird (eds.): The pharmacological basis of therapeutics, McGraw Hill, New York, USA 1996, pp. 161-176.
34. Worek F., Widmann R., Knopff O., Szinicz L.: Reactivating potency of obidoxime, pralidoxime, HI-6 and HLö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch. Toxicol. 72:237-243, 1998.